8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain

Respiratory Physiology and Neurobiology

Volumn 161, Issue 1, 2008, Pages 10-15

  Stettner, Georg M ^a   Zanella, Sébastien ^b   Hilaire, Gérard ^b   Dutschmann, Mathias ^a,c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Deutsche Forschungsgemeinschaft   (Germany)

Author keywords

Apnea of prematurity; Neuronal control of breathing; OSAS; Serotonin; Spontaneous central apnea; Upper airway control

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APNEA; ARTERY PERFUSION; ARTICLE; BODY PLETHYSMOGRAPHY; BRAIN STEM; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HEART; MOUSE; NONHUMAN; PRIORITY JOURNAL; WAKEFULNESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; MICE; MICE, INBRED C57BL; PLETHYSMOGRAPHY, WHOLE BODY; SEROTONIN AGONISTS; SLEEP APNEA, CENTRAL;

EID: 40049086945     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2007.11.001     Document Type: Article

References (26)

1. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
2. Bevengut, M., Coulon, P., Hilaire, G., in press. Brain nuclei controlling the spinal respiratory motoneurons in the newborn mouse. In: Wilson, M. (Ed.). Integration in Respiratory Control - from Genes to Systems. Advances in Experimental Medicine and Biology. Springer Publishers, New York.
3. Bou-Flores C., Lajard A.M., Monteau R., De Maeyer E., Seif I., Lanoir J., and Hilaire G. Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess. J. Neurosci. 20 (2000) 4646-4656
4. Carley D.W., and Radulovacki M. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am. J. Respir. Crit. Care. Med. 160 (1999) 1824-1829
5. Carley D.W., Depoortere H., and Radulovacki M. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats. Pharmacol. Biochem. Behav. 69 (2001) 283-289
6. Choi H., Liao W.L., Newton K.M., Onario R.C., King A.M., Desilets F.C., Woodard E.J., Eichler M.E., Frontera W.R., Sabharwal S., and Teng Y.D. Respiratory abnormalities resulting from midcervical spinal cord injury and their reversal by serotonin 1A agonists in conscious rats. J. Neurosci. 25 (2005) 4550-4559
7. El-Khatib M.F., Kiwan R.A., and Jamaleddine G.W. Buspirone treatment for apneustic breathing in brain stem infarct. Respir. Care. 48 (2003) 956-958
8. Erickson J.T., Shafer G., Rossetti M.D., Wilson C.G., and Deneris E.S. Arrest of 5HT neuron differentiation delays respiratory maturation and impairs neonatal homeostatic responses to environmental challenges. Respir. Physiol. Neurobiol. 159 (2007) 85-101
9. Gaytan S.P., Pasaro R., Coulon P., Bevengut M., and Hilaire G. Identification of central nervous system neurons innervating the respiratory muscles of the mouse: a transneuronal tracing study. Brain. Res. Bull. 57 (2002) 335-339
10. Han F., and Strohl K.P. Inheritance of ventilatory behavior in rodent models. Respir. Physiol. 121 (2000) 247-256
11. Hilaire G., and Duron B. Maturation of the mammalian respiratory system. Physiol. Rev. 79 (1999) 325-360
12. Ide S., Itoh M., and Goto Y. Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci. Lett. 386 (2005) 14-17
13. Lalley P.M., Bischoff A.M., and Richter D.W. Serotonin 1A-receptor activation suppresses respiratory apneusis in the cat. Neurosci. Lett. 172 (1994) 59-62
14. Mendelson W.B., Maczaj M., and Holt J. Buspirone administration to sleep apnea patients. J. Clin. Psychopharmacol. 11 (1991) 71-72
15. Mendelson W.B., Martin J.V., Perlis M., Giesen H., Wagner R., and Rapoport S.I. Periodic cessation of respiratory effort during sleep in adult rats. Physiol. Behav. 43 (1988) 229-234
16. Paterson D.S., Trachtenberg F.L., Thompson E.G., Belliveau R.A., Beggs A.H., Darnall R., Chadwick A.E., Krous H.F., and Kinney H.C. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 296 (2006) 2124-2132
17. Radulovacki M., Trbovic S.M., and Carley D.W. Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rats. Sleep 21 (1998) 131-136
18. Richter D.W., Manzke T., Wilken B., and Ponimaskin E. Serotonin receptors: guardians of stable breathing. Trends Mol. Med. 9 (2003) 542-548
19. Sahibzada N., Ferreira M., Wasserman A.M., Taveira-DaSilva A.M., and Gillis R.A. Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J. Pharmacol. Exp. Ther. 292 (2000) 704-713
20. Sato T., Saito H., Seto K., and Takatsuji H. Sleep apneas and cardiac arrhythmias in freely moving rats. Am. J. Physiol. 259 (1990) R282-R287
21. Smith I., Lasserson T.J., and Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane. Database. Syst. Rev. 2 (2006) CD003002
22. Stettner G.M., Huppke P., Brendel C., Richter D.W., Gartner J., and Dutschmann M. Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J. Physiol. 579 (2007) 863-876
23. Stettner G.M., Zanella S., Huppke P., Gärtner J., Hilaire G., and Dutschmann M. Spontaneous central apneas occur in the C57BL/6J mouse strain. Respir. Physiol. Neurobiol. 160 (2008) 21-27
24. Teng Y.D., Bingaman M., Taveira-DaSilva A.M., Pace P.P., Gillis R.A., and Wrathall J.R. Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats. J. Neurosci. 23 (2003) 4182-4189
25. Viemari J.C., Roux J.C., Tryba A.K., Saywell V., Burnet H., Pena F., Zanella S., Bevengut M., Barthelemy-Requin M., Herzing L.B., Moncla A., Mancini J., Ramirez J.M., Villard L., and Hilaire G. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci. 25 (2005) 11521-11530
26. Wilken B., Lalley P., Bischoff A.M., Christen H.J., Behnke J., Hanefeld F., and Richter D.W. Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist. J. Pediatr. 130 (1997) 89-94